Hypoparathyroidism Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ENTX | F | Entera Bio Ltd. | 5.16 | |
RANI | F | Rani Therapeutics Holdings, Inc. | -0.98 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HRTS | D | Tema Cardiovascular and Metabolic ETF | 0.31 | |
VTI | A | Vanguard Total Stock Market ETF | 0.0 | |
VXF | B | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Nov 20 | RANI | RANI: Third Quarter Update |
- Hypoparathyroidism
Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid hormone. This can lead to low levels of calcium in the blood, often causing cramping and twitching of muscles or tetany (involuntary muscle contraction), and several other symptoms. It is a very rare disease. The condition can be inherited, but it is also encountered after thyroid or parathyroid gland surgery, and it can be caused by immune system-related damage as well as a number of rarer causes. The diagnosis is made with blood tests, and other investigations such as genetic testing depending on the results. The primary treatment of hypoparathyroidism is calcium and vitamin D supplementation. Calcium replacement or vitamin D can ameliorate the symptoms but can increase the risk of kidney stones and chronic kidney disease. However teriparatide, brand name Forteo, a biosimilar peptide to parathyroid hormone, may be given by injection.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles